Catalyst Wire Dossier Catalyst Wire Dossier

FUROSCIX

Furosemide injection 80 mg/10 mL · scPharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for FUROSCIX, covering 2022-10-07 to 2026-07-23. Get the full timeline:

Most recent: FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation)

See pricing